Quality of Chemoradiotherapy in Esophageal Adenocarcinoma Matters

Christina T Muijs¹, Maaike Berbee¹, Peter S N van Rossum¹+4

• ¹Christina T. Muijs, MD, PhD, Department of Radiation Oncology, University Medical Center Groningen, Groningen, the Netherlands, Maaike Berbee, MD, PhD, Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands, Peter S.N. van Rossum, MD, PhD, Department of Radiation Oncology, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands, Nadia Haj Mohammad, MD, PhD, Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands, Bas Wijnhoven, MD, PhD, Department of Surgery, Erasmus University Medical Center, University of Rotterdam, Rotterdam, the Netherlands, Hanneke W.M. Van Laarhoven, MD, PhD, Department of Medical Oncology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands, Karin M. Haustermans, MD, PhD, Department of Radiation Oncology, KU Leuven, Leuven University, Leuven, Belgium.